Electromed (ELMD) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.06% |
| Dec 31, 2025 | 18.06% |
| Sep 30, 2025 | 31.90% |
| Jun 30, 2025 | 11.00% |
| Mar 31, 2025 | 23.69% |
| Dec 31, 2024 | 10.68% |
| Sep 30, 2024 | 7.76% |
| Jun 30, 2024 | 10.90% |
| Mar 31, 2024 | 33.44% |
| Dec 31, 2023 | 34.49% |
| Sep 30, 2023 | -0.28% |
| Jun 30, 2023 | 1.60% |
| Mar 31, 2023 | 23.35% |
| Dec 31, 2022 | 18.41% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | -16.55% |
| Mar 31, 2022 | -0.09% |
| Dec 31, 2021 | 13.55% |
| Sep 30, 2021 | 18.09% |
| Jun 30, 2021 | 3.47% |
| Mar 31, 2021 | -13.65% |
| Dec 31, 2020 | 2.43% |
| Sep 30, 2020 | 9.43% |
| Jun 30, 2020 | 38.68% |
| Mar 31, 2020 | 77.35% |
| Dec 31, 2019 | 22.90% |
| Sep 30, 2019 | 21.86% |
| Jun 30, 2019 | 30.27% |
| Mar 31, 2019 | 18.65% |
| Dec 31, 2018 | 29.13% |
| Sep 30, 2018 | 19.81% |
| Jun 30, 2018 | 33.83% |
| Mar 31, 2018 | 23.51% |
| Dec 31, 2017 | 24.75% |
| Sep 30, 2017 | 25.70% |
| Jun 30, 2017 | 48.82% |
| Mar 31, 2017 | 46.78% |
| Dec 31, 2016 | 78.41% |
| Sep 30, 2016 | -4.88% |
| Jun 30, 2016 | 15.48% |
| Mar 31, 2016 | -0.87% |
| Dec 31, 2015 | 29.61% |
| Sep 30, 2015 | 24.92% |